Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets

v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 18,900 $ 17,198
Investments 113,887 131,864
Restricted cash 285 285
Prepaid expenses and other current assets 4,288 3,629
Total current assets 137,360 152,976
Property and equipment, net 304 385
Restricted cash 385 385
Operating lease right of use assets 1,882 2,133
Total assets 139,931 155,879
Current liabilities:    
Accounts payable 4,068 4,786
Accrued expenses 5,902 5,426
Operating lease liabilities, current 1,650 1,606
Total current liabilities 11,620 11,818
Operating lease liabilities, noncurrent 1,205 1,633
Total liabilities 12,825 13,451
Stockholders' equity    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued and outstanding at March 31, 2025 and December 31, 2024. 0 0
Common stock, $0.0001 par value; 300,000,000 shares authorized, 12,232,853 and 12,179,482 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 1 1
Additional paid-in capital 620,999 619,285
Accumulated deficit (493,871) (476,893)
Accumulated other comprehensive (loss) gain (23) 35
Total stockholders’ equity 127,106 142,428
Total liabilities and stockholders’ equity $ 139,931 $ 155,879